Compare Davita Inc (DVA) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Wells Fargo & Co — how do they compare? Davita Inc trades at $179.05 (market cap $11.29B), while Wells Fargo & Co trades at $83.73 (market cap $248.06B). The key difference: Wells Fargo & Co is far larger — about 22× Davita Inc's market cap, and Wells Fargo & Co pays a 2.44% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 114 Days and Wells Fargo & Co for 88 Days on average.
| DVA | WFC | |
|---|---|---|
Market Cap | $11.29B | $248.06B |
Volume | 582,204 | 16,615,741 |
Sector | Health | Financials |
52-Week High | $240.96 | $96.40 |
52-Week Low | $103.87 | $73.42 |
Typical Hold Time | 114 Days | 88 Days |
Enterprise Value | $24.01B | $503.91B |
Dividend Yield | — | 2.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $179.25, up 1.4% with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows mixed technical signals with bearish moving averages but neutral oscillators, trading near resistance at $179. Fundamentally, revenue growth continues with 2025 revenue reaching $13.64B, though net margins compressed to 5.47% from 7.3% in 2024. Recent partnership expansion with Humana for value-based kidney care represents significant growth opportunity.
Outlook remains positive with analyst consensus target of $235.67 implying 31% upside, though elevated debt levels and regulatory risks require monitoring. The company benefits from demographic tailwinds in kidney care services and strong institutional support, including Berkshire Hathaway's 45% stake, providing stability amid market volatility.
Wells Fargo (WFC) trades at $83.55, up 4.1% today, showing strong momentum despite a bearish technical signal. The stock offers attractive valuation with P/E of 11.92 and P/B of 1.5, supported by improving profitability with net margin reaching 25.97% in 2025. Recent positive developments include a credit rating upgrade to 'A-' by S&P and upcoming Q3 2026 earnings on October 13th. The company maintains solid fundamentals with $21.34B net income and 13.13% ROE, though cash flow volatility remains a concern.
WFC presents a compelling value opportunity with analyst consensus target of $99.13 (18.6% upside) and strong institutional support. However, investors face risks from inconsistent earnings performance (two recent misses), regulatory uncertainty from Fed stress test changes, and volatile cash flow patterns. The stock's technical weakness contrasts with fundamental strength, creating potential for convergence if upcoming earnings beat expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
